177 related articles for article (PubMed ID: 26410578)
1. Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications.
D'Oronzo S; Stucci S; Tucci M; Silvestris F
Cancer Treat Rev; 2015 Nov; 41(9):798-808. PubMed ID: 26410578
[TBL] [Abstract][Full Text] [Related]
2. [Prostate cancer and Cancer Treatment-Induced Bone Loss(CTIBL)].
Matsushima H
Clin Calcium; 2016 Jul; 26(7):1039-45. PubMed ID: 27346316
[TBL] [Abstract][Full Text] [Related]
3. Osteopenia and osteoporosis in pediatric patients after stem cell transplant.
Rodgers C; Monroe R
J Pediatr Oncol Nurs; 2007; 24(4):184-9. PubMed ID: 17588890
[TBL] [Abstract][Full Text] [Related]
4. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
5. Cancer-treatment-induced bone loss, part 2.
Michaud LB; Goodin S
Am J Health Syst Pharm; 2006 Mar; 63(6):534-46. PubMed ID: 16522890
[TBL] [Abstract][Full Text] [Related]
6. Bone health in adult cancer survivorship.
Lustberg MB; Reinbolt RE; Shapiro CL
J Clin Oncol; 2012 Oct; 30(30):3665-74. PubMed ID: 23008309
[TBL] [Abstract][Full Text] [Related]
7. Alcoholic liver disease and changes in bone mineral density.
López-Larramona G; Lucendo AJ; González-Delgado L
Rev Esp Enferm Dig; 2013; 105(10):609-21. PubMed ID: 24641458
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis.
Camacho PM; Dayal AS; Diaz JL; Nabhan FA; Agarwal M; Norton JG; Robinson PA; Albain KS
J Clin Oncol; 2008 Nov; 26(33):5380-5. PubMed ID: 18955450
[TBL] [Abstract][Full Text] [Related]
9. Cancer-treatment-induced bone loss, part 1.
Michaud LB; Goodin S
Am J Health Syst Pharm; 2006 Mar; 63(5):419-30. PubMed ID: 16484516
[TBL] [Abstract][Full Text] [Related]
10. NCCN Task Force Report: Bone Health and Cancer Care.
Theriault RL; Biermann JS; Brown E; Brufsky A; Demers L; Grewal RK; Guise T; Jackson R; McEnery K; Podoloff D; Ravdin P; Shapiro CL; Smith M; Van Poznak CH
J Natl Compr Canc Netw; 2006 May; 4 Suppl 2():S1-20; quiz S21-2. PubMed ID: 16737674
[TBL] [Abstract][Full Text] [Related]
11. [ RANKL antibody for treatment of cancer treatment-induced bone loss (CTIBL)].
Takahashi S
Clin Calcium; 2011 Aug; 21(8):1239-47. PubMed ID: 21814031
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bone loss: pathogenesis and therapeutic intervention.
Redlich K; Smolen JS
Nat Rev Drug Discov; 2012 Mar; 11(3):234-50. PubMed ID: 22378270
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis in breast and prostate cancer survivors.
Hoff AO; Gagel RF
Oncology (Williston Park); 2005 Apr; 19(5):651-8. PubMed ID: 15945345
[TBL] [Abstract][Full Text] [Related]
14. Cancer treatment-induced bone loss in breast and prostate cancer.
Saad F; Adachi JD; Brown JP; Canning LA; Gelmon KA; Josse RG; Pritchard KI
J Clin Oncol; 2008 Nov; 26(33):5465-76. PubMed ID: 18955443
[TBL] [Abstract][Full Text] [Related]
15. Moving into the future: treatment of bone metastases and beyond.
Hortobagyi GN
Cancer Treat Rev; 2005; 31 Suppl 3():9-18. PubMed ID: 16249057
[TBL] [Abstract][Full Text] [Related]
16. Osteopenia and osteoporosis in anorexia nervosa.
Golden NH
Adolesc Med; 2003 Feb; 14(1):97-108. PubMed ID: 12529194
[TBL] [Abstract][Full Text] [Related]
17. Bone health in breast cancer survivors.
Abdel-Razeq H; Awidi A
J Cancer Res Ther; 2011; 7(3):256-63. PubMed ID: 22044804
[TBL] [Abstract][Full Text] [Related]
18. Osteopenia in the patient with cancer.
Croarkin E
Phys Ther; 1999 Feb; 79(2):196-201. PubMed ID: 10029059
[TBL] [Abstract][Full Text] [Related]
19. Bone health and multiple sclerosis.
Dobson R; Ramagopalan S; Giovannoni G
Mult Scler; 2012 Nov; 18(11):1522-8. PubMed ID: 22740489
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and management of osteoporosis in liver disease.
Hay JE; Guichelaar MM
Clin Liver Dis; 2005 Nov; 9(4):747-66, viii. PubMed ID: 16207574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
